Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Director's Report to the National Advisory Council on Drug Abuse
September, 2001

Planned Meetings

On September 23-26, 2001, NIDA will sponsor a science-based institute in Denver, CO. The Demand Treatment Leadership Institute II will target community-based teams involved in Join Together's Demand Treatment! initiative.

As part of its Health Disparities Strategic Plan, NIDA will convene a national conference on drug abuse research in minority populations entitled Bridging Science and Culture to Improve Drug Abuse Research in Minority Communities on September 24-26, 2001 in Philadelphia.

Ana Anders, as President of the NIH/Hispanic Employee Organization (HEO), is planning the Hispanic Heritage Month Celebration for NIH that will be held September 19 and October 1, 2001.

The American Psychological Association will hold a conference Enhancing Outcomes in Women's Health: Translating Psychosocial and Behavioral Research Into Primary Care, Community Interventions and Health Policy - An Interdisciplinary Conference in Washington, DC, October 4-6, 2001. This conference, which is co-funded by NIDA, will include three NIDA sponsored symposia. The first, "The Convergence of Drug Abuse, Sex, and Violence," co-organized by Helen Cesari and Elizabeth Lambert, will be chaired by Elizabeth Lambert, and will feature Claire E. Sterk, Ph.D., (Emory University), Stephanie Tortu, Ph.D., (Tulane University), Nabila El-Bassel, Ph.D., (Columbia University), and Patricia Case, Ph.D. (Harvard Medical School) as presenters, with Deborah Smith, M.D. in the role of discussant. The second symposium, organized by Dionne Jones, Ph.D. will feature Sally J. Stephens, Ph.D. (University of Arizona), Murelle G. Harrison, Ph.D. (Southern University, Baton Rogue, LA), Suzanne Montgomery, Ph.D. (Loma Linda University), and M. Bahati Kuumba, Ph.D. (Spelman College) as presenters, with Dionne Jones, Ph.D. in the role of chairperson and discussant. The third symposium, co-organized by Dorynne Czechowicz, M.D. and Adele Roman will be chaired by Cora Lee Wetherington, Ph.D. and will feature Wendee M. Wechsberg, Ph.D. (Research Triangle Institute), Karla Moras, Ph.D. (University of Pennsylvania), Lisa M. Najavits, Ph.D. (Harvard Medical School), and Heidi Resnick, Ph.D. (National Crime Victims Research and Treatment Center) as presenters, with Mary E. McCaul Ph.D. (Johns Hopkins University) in the role of discussant.

A NIDA sponsored Workshop Using Buprenorphine in Office-Based Practice will be held on Monday, October 8, 2001, at the American Methadone Treatment Association Meeting in St. Louis, Missouri. Dr. Czechowicz, Robert Walsh and Dr. Frank Vocci, DTR&D organized this session.

The 4th Annual Meeting of the Global Research Network (GRN) on HIV Prevention in Drug-Using Populations will be held October 11- 12, 2001 in Melbourne, Australia, immediately following the 6th International Congress on AIDS in Asia and the Pacific (ICAAP) on October 5-10. Three symposia in the 6th ICAAP meeting are sponsored by the GRN, in addition to a roundtable and a workshop on research and training opportunities at the NIH. The GRN meeting will include four major sessions, on the research implications of IDUs as multipliers of HIV to the general population, on challenges for HIV prevention in Asia and the Pacific Islands, on the GRN's indicators database on HIV prevention in drug users, and on the GRN's mission and future plans. In addition to NIDA, the GRN's co-sponsoring organizations are the Joint U.N. Programme on HIV/AIDS, Health Canada, the WHO, the U.N. Office of Drug Control and Crime Prevention, CDC, and the NIH's Office of AIDS Research and the Fogarty International Center. Henry I. Francis, M.D., Director of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA) and Helen Cesari, M.Sc., Chief of CAMCODA's Population-Based Health Intervention, will be participating in both the ICAAP and GRN meetings.

NIDA will host its Seventh Constituent Conference at the Westfields Marriott in Chantilly, Virginia, December 3-4, 2001. This conference provides NIDA and constituent organization leaders with the opportunity for dialog and gives NIDA the chance to receive and respond to the concerns and research recommendations from the field. NIDA also uses this setting to present the field with its latest research findings.

Dr. Steven Grant, DTR&D, will be co-chairing a symposium entitled Transition to Addiction: Does Pushing the Lever Pull the Switch? at the upcoming annual meeting of the American College for Neuropsychopharmacology in December 2001. Speakers at the symposium are James Anthony, Johns Hopkins University, Elliot Stein, Medical College of Wisconsin, Linda Porrino, Wake Forrest University, Barry Everitt, Cambridge University.

National CTN Steering Committee Meetings are planned for the follow dates and locations: October 22-24, 2001, in Bethesda, MD, January 28-30, 2002, in Charleston, South Carolina, and March 13, 2002, in New York City.

The CTN Data and Safety Monitoring Board will meet September 17-18, 2001, in Bethesda, Maryland.

[Office of the Director][Report Index][Next Report Section]

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal